Skip to content

EUCROF25 Speakers

EUCROF25 brings together leading industry experts to deliver an extensive array of presentations, expert panel discussions, interactive workshops, and breakout sessions. Speakers will share their vast knowledge and experiences on the multifaceted nature of clinical research, covering essential topics such as regulatory changes, clinical trial technologies, quality assurance, data management, and patient-centric approaches.

Meet the EUCROF25 Speakers below.

Keynote Speakers

Peter Arlett

The European Medicines Agency

Monique Al

Central Committee on Research Involving Human Subjects, The Netherlands

Richelle Flanagan

My Moves Matter

Speakers

Lene Grejs Petersen

Danish Medicines Agency

Annika Baan

CTU oncology Sahlgrenska Comprehensive Cancer Center Sweden

Eleanor McLaurin

Medidata, Dassault Systèmes

Joachim Lövin

Novo Nordisk A/S

Łukasz Izbicki

ClinicalTrials.eu

Majd Mirza

Viedoc Technologies

Melissa Herman

H. Lundbeck A/S

Dominique Hamerlijnck

European Lung Foundation

Dipak Kalra

The European Institute for Innovation through Health Data

Atiye Nazari

Nestlé Research

Karen Gabriels

Archer Research

Łukasz Wiech

ClinicalTrials.eu

Eva Adås

Johnson & Johnson Innovative Medicine

Mieke Tempels

Archer Research

Audrey Van Scharen

Belgian Association of Research Ethics Committees

Kevin Machado Gamboa

Medidata, Dassault Systèmes

Szilvia Harsányi

Research Professionals Ltd.

Valerie Nadugo Tumaliuan

Region 1 Medical Center

Terttu Haring

SGM Alliance

Gabriele Schwarz

Federal Institute for Drugs and Medical Devices (BfArM)

Torsten Stemmler

Federal Institute for Drugs and Medical Devices

Begonya Nafria Escalera

Sant Joan de Déu Research Foundation

Geert Briers

Deltaclinical

Maria Veleva

Velev Consulting Ltd

Novilyn Villanueva

Region 1 Medical Center

Tanja A.M. Hoffman

TNJ Life Sciences Consultancy

Paul O'Donohoe

Medidata, Dassault Systèmes

Programme

The EUCROF25 programme aims to further enrich the dialogue and cooperation across the spectrum of clinical research sectors. Sessions will reflect the current state of clinical research while also exploring the pressing challenges and exciting opportunities that lie ahead.

Back to top